Full profile interview: Company Financials
5 Oct 2026

Sava Technologies
4 Aug 2026

How CGMs are Riding the GLP-1 Wave to Transform Metabolic Health
The healthcare landscape is undergoing its most seismic shift in a generation. The catalyst is the explosive rise of GLP-1 receptor agonists like semaglutide and tirzepatide. Originally developed for type 2 diabetes, these medications have transformed into global blockbusters for weight management and metabolic health.
16 Jun 2026

FDA Approval of Glucose Monitor Explodes New Over-the-Counter Market
A metabolic crisis is quietly sweeping through American youths, transforming paediatric prediabetes into one of the country's most urgent health emergencies. Recognising the acute need for accessible intervention, the U.S. Food and Drug Administration (FDA) achieved a historic milestone by expanding the clearance of Dexcom's Stelo Glucose Biosensor System for paediatric use without a prescription.
Full profile interview: IDTechEx Index
1 Jun 2026

Roche Diabetes Care
Update
31 May 2026

Insulet
Insulet is a US-based medical device company that develops and sells a wearable and tubeless infusion pump. The company has commercialized the Omnipod series of insulin patch pumps.
Update
31 May 2026

CamDiab
CamDiab Ltd is a UK-based startup that has developed the CamAPS FX, a smartphone app for hybrid closed-loop adjustment of insulin for people with Type 1 diabetes. A key player in the automated insulin delivery (AID) market.
Full profile interview
28 May 2026

MiniMed
MiniMed is an independent, newly public medical technology company that leverages advanced, AI-driven closed-loop systems and a high-margin recurring consumable model to automate global diabetes management.
Full profile interview
28 May 2026

Dexcom
Dexcom is a US-based biotech company, founded in 1999. The company is one of the market leaders in the continuous glucose monitoring (CGM) industry.
Full profile interview
17 May 2026

Abbott Diabetes Care
Abbott Diabetes Care is a division of American multinational company Abbott Laboratories. Today, Abbott Diabetes Care is a major player in the continuous glucose monitoring market — the company's "Freestyle" brand of continuous glucose monitors (CGMs) is believed to be the most widely used CGM device.
Included are:
Full profile interview: Company Financials
15 May 2026

Sinocare Inc
The largest individual funding stakeholder, directly controlling 25.8% of the company's equity
Appears in IDTechEx Report

24 Nov 2025
Sensor Market 2026-2036: Technologies, Trends, Players, Forecasts
IDTechEx Report: Mika Takahashi, Dr Conor O'Brien, Noah El Alami, Daniel Parr, Shihao Fu, Dr Yu-Han Chang and Dr Xiaoxi He
28 Feb 2025

Trends In Artificial Pancreas Technologies And Future Directions
Diabetes is a chronic condition that affects millions of people worldwide. The condition requires close and careful management to avoid severe health consequences. Today, people with diabetes have access to sophisticated automated insulin dosing (AID) systems that help in many aspects of diabetes management. IDTechEx forecasts that with further developments in AID systems, the diabetes management market can reach US$44 billion by 2035.
Innovation Map
20 Jan 2025

Insulin Delivery
Innovation map for insulin delivery.
Innovation Map
20 Jan 2025

Continuous Glucose Monitoring
Innovation map of continuous glucose monitoring.
Innovation Map
14 Jan 2025

Blood Glucose Sensing
Innovation map of blood glucose sensing.
Update
4 Nov 2024

CamDiab
CamDiab Ltd is a UK-based startup that has developed the CamAPS FX, a smartphone app for hybrid closed-loop adjustment of insulin for people with Type 1 diabetes.
Update
31 Oct 2024

SOOIL Development
SOOIL is a Korean medical device company focusing on diabetes management technology. The company sells the DANA series of insulin pumps.